Sanofi eliminates a series of existing client distribution companies in Boehringer’s OTC business

It was told as Sanofi acquires the Boehringer Ingelheim’s OTC business, Sanofi stopped having businesses with a number of its existing client pharmaceutical distribution.

Because the distribution companies whose business was terminated need to work as an agent for other distribution companies, they are complaining that they need to purchase products with even higher margins.

At the beginning ...